prev | Main Index | next
Supplemental
New Animal Drug Approvals
Company
Generic and (Brand) Names
Indications
Routes/Remarks
Alpharma, Inc.
(NADA 107-996)
Lasalocid (Avatec), Bacitracin Methylene Disalicylate (BMD)
Chickens. For the prevention of coccidiosis, increased rate of weight gain,
and improved feed efficiency.
MEDICATED FEED—The supplemental NADA provides for a zero-day withdrawal period
for the use of approved two-way combination drug Type C medicated feeds containing
lasalocid and bacitracin methylene disalicylate in broiler and fryer chickens.
Federal Register 03/31/03
Schering-Plough Animal Health Corp.
(NADA 141-177)
Gentamicin sulfate, Mometasone furoate, Clotrimazole
(MometamaxTM) RX
Dogs. For treatment of otitis externa.
OTIC—The supplemental NADA provides for the addition of once-daily administration
to the dosage regimens for gentamicin/mometasone/clotrimazole otic suspension
used to treat otitis externa in dogs.
Federal Register 03/31/03
Novartis Animal Health, Inc.
(NADA 141-203)
Deracoxib (DeramaxxTM) RX
Dogs. For the control of pain and inflammation.
ORAL—The supplement provides for veterinary prescription use of deracoxib chewable
tablets for the control of pain and inflammation associated with osteoarthritis.
Federal Register 04/17/03
|
These pages were produced by GetCVM, a content gathering spider from SpiderMakers.
GetCVM lets you easily produce a complete set
of articles for your website.
The text in this box is an example of a footer that
we created for GetCVM to include on all these generated pages. You can easily customize this
footer for your own purposes.
GetCVM is available today from SpiderMakers.
|
prev | next
Source: May/June 2003 FDA Newsletter
Main Index
This page produced by GetCVM, a digital spider from SpiderMakers
|